Compare ELPC & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELPC | CAI |
|---|---|---|
| Founded | 1954 | 2008 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 7.2B |
| IPO Year | N/A | 2025 |
| Metric | ELPC | CAI |
|---|---|---|
| Price | $10.39 | $28.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $34.43 |
| AVG Volume (30 Days) | 2.6K | ★ 2.4M |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 3.85% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $4,681,123,759.00 | $649,062,000.00 |
| Revenue This Year | N/A | $77.69 |
| Revenue Next Year | $6.83 | $35.80 |
| P/E Ratio | $18.62 | ★ N/A |
| Revenue Growth | 12.38 | ★ 112.02 |
| 52 Week Low | $5.04 | $22.86 |
| 52 Week High | $10.51 | $42.50 |
| Indicator | ELPC | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 63.20 | N/A |
| Support Level | $10.03 | N/A |
| Resistance Level | $10.32 | N/A |
| Average True Range (ATR) | 0.15 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 100.00 | 0.00 |
Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Services, and Holding. The majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.